Stephen J. Harding

599 total citations
18 papers, 405 citations indexed

About

Stephen J. Harding is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology and Molecular Biology. According to data from OpenAlex, Stephen J. Harding has authored 18 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Stephen J. Harding's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Multiple Myeloma Research and Treatments (9 papers) and Glycosylation and Glycoproteins Research (4 papers). Stephen J. Harding is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Multiple Myeloma Research and Treatments (9 papers) and Glycosylation and Glycoproteins Research (4 papers). Stephen J. Harding collaborates with scholars based in United Kingdom, France and New Zealand. Stephen J. Harding's co-authors include A.R. Bradwell, Hugh D Carr-Smith, Graham P. Mead, Mark T. Drayson, Gregg Wallis, Dejan Milosavljevic, Niklas Zojer, Jeff Faint, Heinz Ludwig and Wolfgang Hübl and has published in prestigious journals such as Blood, PLoS ONE and Diabetes Care.

In The Last Decade

Stephen J. Harding

18 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen J. Harding United Kingdom 11 236 230 110 75 73 18 405
Christopher B. Hopson United States 8 109 0.5× 370 1.6× 29 0.3× 92 1.2× 53 0.7× 13 514
Qingshu Zeng China 9 77 0.3× 348 1.5× 13 0.1× 62 0.8× 34 0.5× 23 451
Anri Tienhaara Finland 10 167 0.7× 220 1.0× 21 0.2× 45 0.6× 161 2.2× 20 412
Nazir Jamal Canada 6 92 0.4× 74 0.3× 33 0.3× 38 0.5× 101 1.4× 9 270
Benoît Guillet France 14 110 0.5× 479 2.1× 12 0.1× 146 1.9× 25 0.3× 46 578
Elizabeth I. Valoret United States 5 84 0.4× 343 1.5× 11 0.1× 91 1.2× 27 0.4× 5 438
Christy Samaras United States 13 302 1.3× 264 1.1× 10 0.1× 97 1.3× 189 2.6× 57 437
Ahmed Awad United States 5 118 0.5× 35 0.2× 19 0.2× 17 0.2× 50 0.7× 8 355
Raja Mudad United States 15 44 0.2× 107 0.5× 21 0.2× 45 0.6× 174 2.4× 35 435
Kenneth D. Herbst United States 8 57 0.2× 70 0.3× 105 1.0× 87 1.2× 45 0.6× 14 358

Countries citing papers authored by Stephen J. Harding

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Harding more than expected).

Fields of papers citing papers by Stephen J. Harding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Harding. The network helps show where Stephen J. Harding may publish in the future.

Co-authorship network of co-authors of Stephen J. Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Harding. A scholar is included among the top collaborators of Stephen J. Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Harding. Stephen J. Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rögnvaldsson, Sæmundur, Sigrún Þorsteinsdóttir, Þórir Einarsson Long, et al.. (2024). The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study. Blood Cancer Journal. 14(1). 221–221. 2 indexed citations
2.
Evans, Neil D., et al.. (2019). Parameter Identification for a Model of Neonatal Fc Receptor-Mediated Recycling of Endogenous Immunoglobulin G in Humans. Frontiers in Immunology. 10. 674–674. 5 indexed citations
3.
Fenton, Anthony, Mark Jesky, Rachel Webster, et al.. (2018). Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease. PLoS ONE. 13(5). e0197043–e0197043. 6 indexed citations
4.
Harding, Stephen J., et al.. (2017). Serum Free Light Chain (FLC) Analysis: A Guiding Light in Monoclonal Gammopathy Management. The Journal of Applied Laboratory Medicine. 2(1). 98–106. 4 indexed citations
5.
Jesky, Mark, Stephanie Stringer, Anthony Fenton, et al.. (2016). Serum tryptase concentration and progression to end‐stage renal disease. European Journal of Clinical Investigation. 46(5). 460–474. 21 indexed citations
6.
Carr-Smith, Hugh D, et al.. (2016). Analytical issues of serum free light chain assays and the relative performance of polyclonal and monoclonal based reagents. Clinical Chemistry and Laboratory Medicine (CCLM). 54(6). 997–1003. 27 indexed citations
7.
Berlanga, Oscar, et al.. (2015). Quantification of β-region IgA monoclonal proteins – should we include immunochemical Hevylite® measurements? Point. Clinical Chemistry and Laboratory Medicine (CCLM). 54(6). 1053–7. 4 indexed citations
8.
Hutchison, Colin A., Stephen J. Harding, Kolitha Basnayake, et al.. (2014). Serum Polyclonal Immunoglobulin Free Light Chain Levels Predict Mortality in People With Chronic Kidney Disease. Mayo Clinic Proceedings. 89(5). 615–622. 39 indexed citations
9.
Basu, Supratik, David Sutton, Philip A. Kalra, et al.. (2014). Quantification of polyclonal free light chains in clinical samples using a single turbidimetric immunoassay. Clinical Chemistry and Laboratory Medicine (CCLM). 0(0). 1605–13. 5 indexed citations
10.
Boyle, Eileen M., Guillemette Fouquet, Stéphanie Guidez, et al.. (2014). IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma. Cancer. 120(24). 3952–3957. 25 indexed citations
11.
Bellary, Srikanth, Lakhvir K. Assi, Colin A. Hutchison, et al.. (2014). Elevated Serum Free Light Chains Predict Cardiovascular Events in Type 2 Diabetes. Diabetes Care. 37(7). 2028–2030. 16 indexed citations
12.
Ludwig, Heinz, Dejan Milosavljevic, Niklas Zojer, et al.. (2012). Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients. Leukemia. 27(1). 213–219. 78 indexed citations
13.
Koulieris, Efstathios, Panayiotis Panayiotidis, Stephen J. Harding, et al.. (2012). Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma. Experimental Hematology and Oncology. 1(1). 9–9. 27 indexed citations
14.
Boyle, Eileen M., Hélène Demarquette, Julie Gay, et al.. (2012). IgA Hevylite® Test As a Surrogate to Serum Protein Electrophoresis (SPEP) or Nephelometry in the Management of IgA Myeloma. Blood. 120(21). 3970–3970. 1 indexed citations
15.
Harding, Stephen J., Gareth J. Browne, Bryan W. Miller, Sally A. Prigent, & Martin Dickens. (2010). Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(9). 733–740. 24 indexed citations
16.
Harding, Stephen J., Graham P. Mead, A.R. Bradwell, & Annie M. Bérard. (2009). Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies. Clinical Chemistry and Laboratory Medicine (CCLM). 47(3). 302–4. 13 indexed citations
17.
Bradwell, A.R., Stephen J. Harding, Gregg Wallis, et al.. (2009). Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ Ratios. Clinical Chemistry. 55(9). 1646–1655. 85 indexed citations
18.
Durrant, Lindy G., et al.. (2006). A New Anticancer Glycolipid Monoclonal Antibody, SC104, which Directly Induces Tumor Cell Apoptosis. Cancer Research. 66(11). 5901–5909. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher B. Hopson Breakdown of academic impact, for papers by Qingshu Zeng Breakdown of academic impact, for papers by Anri Tienhaara Breakdown of academic impact, for papers by Nazir Jamal Breakdown of academic impact, for papers by Benoît Guillet Breakdown of academic impact, for papers by Elizabeth I. Valoret Breakdown of academic impact, for papers by Christy Samaras Breakdown of academic impact, for papers by Ahmed Awad Breakdown of academic impact, for papers by Raja Mudad Breakdown of academic impact, for papers by Kenneth D. Herbst
Rankless by CCL
2026